$4950 | Single User
$9900 | Site License
$14850 | Enterprise License

Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023
[Report Updated: 01-03-2017]

Published by Delve Insight: 01 Mar 2017 | 105345 | In Stock
Related Topics: Acne

Introduction

Acne vulgaris is a common chronic skin disease/Disorder of pilosebaceous follicles. The disease is characterized by blockage and/or inflammation of hair follicles and their accompanying sebaceous gland. Acne develops in regions of high sebaceous gland. The disease is seen to occur mostly in adolescence. At puberty androgens due to the increase in sebum production from enlarged sebaceous glands, the glands become blocked. Propionibacterium acnes further colonise and lead to lesion production although its exact role is unclear.

DelveInsight’s “Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023” Report provides an overview of the disease and market size of the Acne Vulgaris for the global, United States, EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan for 2013-2023. It also includes global historical and forecasted epidemiological data for the Acne Vulgaris Diagnosed Cases from 2013-2023. According to DelveInsight, the Diagnosed cases in 7 major markets for Acne Vulgaris (AV) were 113,959,366 cases in 2013 and are expected to be 136,929,289 cases in 2023.

As per DelveInsight’s estimation, the global market size of Acne Vulgaris (AV) was USD 5,360.1 Millions in 2013 and is expected to reach USD 14,226.3 Million by the end of 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.

- It also provides Market size of Acne Vulgaris (AV) for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.

Acne Vulgaris (AV) Market (7MM)

Acne Vulgaris (AV) Market forecasting

Acne Vulgaris (AV) Sales forecasting

Acne Vulgaris (AV) Market segments

Acne Vulgaris (AV) Epidemiology

Acne Vulgaris (AV) Pipeline products and technologies

Acne Vulgaris (AV) Competitive landscape

Acne Vulgaris (AV) SWOT analysis

Acne Vulgaris (AV) Market Driver’s and barriers

Acne Vulgaris (AV) Key Companies and Funding

Table of Contents
for Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 01-03-2017]

  • Report Introduction

    Acne Vulgaris Market Overview at a Glance

    Total Market Size of Acne Vulgaris for 7 MM in 2010-2023

    Total Market Share Distribution of Acne Vulgaris for 7 MM in 2015

    Total Market Share Distribution of Acne Vulgaris for 7 MM in 2023

    Acne Vulgaris

    Overview

    Signs and symptoms

    Types of Acne

    Pathophysiology

    Diagnosis

    Epidemiology and Patient Population

    United States

    Diagnosed Cases of Acne Vulgaris in United States

    Germany

    Diagnosed Cases of Acne Vulgaris in Germany

    France

    Diagnosed Cases of Acne Vulgaris in France

    United Kingdom

    Diagnosed Cases of Acne Vulgaris in United Kingdom

    Spain

    Diagnosed Cases of Acne Vulgaris in Spain

    Italy

    Diagnosed Cases of Acne Vulgaris in Italy

    Japan

    Diagnosed Cases of Acne Vulgaris in Japan

    Treatment Algorithm

    Marketed Drugs

    Top Marketed Drugs for Acne Vulgaris

    Acanya: Valeant Pharmaceuticals

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Safety and Efficacy of Acanya

    Product Profile

    Tazorac: Allergan

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Safety and Efficacy of Tazorac

    Product Profile

    Veltin: Almirall, S.A.

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Product Profile

    Duac: Glaxosmithkline

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Product Profile

    Epiduo and Epiduo Forte: Galderma S.A.

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Safety and Efficacy of Epiduo

    Product Profile

    Emerging Therapies

    Major Pipeline drugs

    Sarecycline: Paratek Pharmaceuticals

    Regulatory Milestones

    Advantages & Disadvantages

    Product Profile

    Clinical Development

    Clinical Pipeline Activity

    Ongoing Trials Information

    Clinical Trial by Phase

    Aczone reform: Allergan

    Advantages & Disadvantages

    Product Profile

    SB204: Novan, Inc.

    Advantages & Disadvantages

    Product Profile

    Clinical Development

    Clinical Pipeline Activity

    Ongoing Trials Information

    Clinical Trial by Phase

    Global Acne Vulgaris: Country-Wise Market Analysis

    Overview on Total Acne Vulgaris Market (2015)

    Overview on Total Acne Vulgaris Market (2023)

    United States Market Size

    Europe Market Size

    United Kingdom Market Size

    Germany Market Size

    France Market Size

    Italy Market Size

    Spain Market Size

    Japan Market Size

    Market Drivers

    Market Restraints

    Appendix

    Report Methodology

    Consulting Services

    Disclaimer

    About DelveInsight

List Of Tables
in Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 01-03-2017]

Table 1: Diagnosed Cases Acne Vulgaris in United States (2013-2023)

Table 2: Diagnosed Cases Acne Vulgaris in Germany (2013-2023)

Table 3: Diagnosed Cases Acne Vulgaris in France (2013-2023)

Table 4: Diagnosed Cases Acne Vulgaris in United Kingdom (2013-2023)

Table 5: Diagnosed Cases Acne Vulgaris in Spain (2013-2023)

Table 6: Diagnosed Cases Acne Vulgaris in Italy (2013-2023)

Table 7: Diagnosed Cases Acne Vulgaris in Japan (2013-2023)

Table 8: List of Marketed Drugs for Acne Vulgaris

Table 9: List of Pipeline Phase III Drugs for Acne Vulgaris

Table 10: Sarecycline, Clinical Trials by Zone, 2016

Table 11: Clinical Trials by Trial status, 2016

Table 12: SB204, Clinical Trials by Zone, 2016

Table 13: Clinical Trials by Trial status, 2016

Table 14: United States Market Size of Acne Vulgaris in USD, Million (2013-2023)

Table 15: United Kingdom Market Size of Acne Vulgaris in USD, Million (2013-2023)

Table 16: Germany Market Size of Acne Vulgaris in USD, Million (2013-2023)

Table 17: France Market Size of Acne Vulgaris in USD, Million (2013-2023)

Table 18: Italy Market Size of Acne Vulgaris in USD, Million (2013-2023)

Table 19: Spain Market Size of Acne Vulgaris in USD, Million (2013-2023)

Table 20: Japan Market Size of Acne Vulgaris in USD, Million (2013-2023)

List Of Figures, Charts and Diagrams
in Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 01-03-2017]

Figure 1: Cellular mechanisms hypothesized to govern the pathogenesis of Acne Vulgaris

Figure 2: Diagnosed Cases of Acne Vulgaris in United States (2013-2023)

Figure 3: Diagnosed Cases of Acne Vulgaris in Germany (2013-2023)

Figure 4: Diagnosed Cases of Acne Vulgaris in France (2013-2023)

Figure 5: Diagnosed Cases of Acne Vulgaris in United Kingdom (2013-2023)

Figure 6: Diagnosed Cases of Acne Vulgaris in Spain (2013-2023)

Figure 7: Diagnosed Cases of Acne Vulgaris in Italy (2013-2023)

Figure 8: Diagnosed Cases of Acne Vulgaris in Japan (2013-2023)

Figure 9: Sarecycline, Clinical Trials by Zone (%), 2016

Figure 10: Sarecycline, Clinical Trials by Trial status (%), 2016

Figure 11: SB204, Clinical Trials by Zone (%), 2016

Figure 12: SB204, Clinical Trials by Trial status (%), 2016

Figure 13: Total Market Size of Acne Vulgaris in USD, Million (2015)

Figure 14: Total Market Size of Acne Vulgaris in USD, Million (2023)

Figure 15: United States Market Size of Acne Vulgaris in USD, Million (2013-2023)

Figure 16: United Kingdom Market Size of Acne Vulgaris in USD, Million (2013-2023)

Figure 17: Germany Market Size of Acne Vulgaris in USD, Million (2013-2023)

Figure 18: France Market Size of Acne Vulgaris in USD, Million (2013-2023)

Figure 19: Italy Market Size of Acne Vulgaris in USD, Million (2013-2023)

Figure 20: Spain Market Size of Acne Vulgaris in USD, Million (2013-2023)

Figure 21: Japan Market Size of Acne Vulgaris in USD, Million (2013-2023)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

105345 | DIMI0008

Number of Pages

88

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Acne Vulgaris Global Clinical Trials Review, H2, 2018
Acne Vulgaris Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Acn...
25 Oct 2018 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2018
Acne And Related Disorders Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial...
25 Oct 2018 by Global Data USD $2,500 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Acne Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H2, 2016
Acne Vulgaris Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Acn...
27 Jul 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne Vulgaris Global Clinical Trials Review, H1, 2016
Acne Vulgaris Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Acn...
15 Apr 2016 by Global Data USD $2,500 More Info
Acne And Related Disorders Global Clinical Trials Review, H2, 2015
Acne And Related Disorders Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial...
30 Nov 2015 by Global Data USD $2,500 More Info
Global Acne Treatment Market: Trends and Opportunities (2014-2019)
Scope of the ReportThe report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2...
01 Jan 2015 by Daedal Research USD $800 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Acne Vulgaris (AV) - Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 01-03-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...